Public Employees Retirement System of Ohio Invests $3.12 Million in Baxter International Inc. $BAX

Public Employees Retirement System of Ohio acquired a new stake in Baxter International Inc. (NYSE:BAX) in the second quarter, Holdings Channel reports. The institutional investor acquired 146,455 shares of the medical instruments supplier’s stock, valued at approximately $3,122,000.

A number of other large investors also recently added to or reduced their stakes in BAX. Basepoint Wealth LLC bought a new stake in Baxter International in the fourth quarter worth $26,000. Jones Financial Companies Lllp bought a new position in shares of Baxter International during the second quarter valued at about $26,000. Imprint Wealth LLC bought a new position in shares of Baxter International during the third quarter valued at about $27,000. MUFG Securities EMEA plc purchased a new position in shares of Baxter International in the second quarter worth about $46,000. Finally, Los Angeles Capital Management LLC purchased a new position in shares of Baxter International in the fourth quarter worth about $46,000. Hedge funds and other institutional investors own 90.19% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on BAX. Stifel Nicolaus increased their target price on Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Wall Street Zen raised Baxter International from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Weiss Ratings raised Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, July 31st. UBS Group raised their target price on shares of Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. Finally, Wells Fargo & Company lifted their target price on shares of Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Baxter International has an average rating of “Hold” and an average price target of $22.45.

Baxter International Stock Up 0.9%

NYSE BAX opened at $25.81 on Friday. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32. The stock has a market capitalization of $13.34 billion, a PE ratio of -12.47, a PEG ratio of 3.87 and a beta of 0.60. Baxter International Inc. has a 1 year low of $15.73 and a 1 year high of $30.00. The business’s 50-day moving average is $24.73 and its 200 day moving average is $20.72.

Baxter International (NYSE:BAX) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.19. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The business had revenue of $2.96 billion during the quarter, compared to analyst estimates of $2.80 billion. During the same quarter in the prior year, the company posted $0.59 EPS. Baxter International’s quarterly revenue was up 5.3% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Sell-side analysts forecast that Baxter International Inc. will post 2.04 earnings per share for the current year.

Baxter International Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Friday, August 28th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, August 28th. Baxter International’s dividend payout ratio is currently -1.93%.

Baxter International Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.